Prospective randomized trial to assess the efficacy of 0.5% Marcaine subserosal injection in the gall bladder fossa to reduce the post operative pain from laparoscopic cholecystectomy

ISRCTN ISRCTN68753145
DOI https://doi.org/10.1186/ISRCTN68753145
Protocol serial number N0008171900
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Funder Frimley Park Hospital NHS Foundation Trust (UK)
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
06/09/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Amir Nisar
Scientific

Portsmouth Road
Camberley
Camberley
GU16 7UJ
United Kingdom

Phone +44 (0)7859888713
Email dranisar@yahoo.co.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleProspective randomized trial to assess the efficacy of 0.5% Marcaine subserosal injection in the gall bladder fossa to reduce the post operative pain from laparoscopic cholecystectomy
Study objectivesPain after Laparoscopic Cholecystectomy (key hole removal of gall bladder) is much lower than an open operation for the removal of gall bladder. However one can still expect mild to moderate pain after the key hole operation.
Can we reduce the post operative pain after the key hole operation by injecting local anaesthetic in the gall bladder bed?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSigns and Symptoms: Pain
InterventionWe will recruit every suitable patient who undergoes a Laparoscopic Cholecystectomy under either of the Upper Gastrointestinal Surgeons at Frimley Park Hospital.
They will be given information leaflet about Laparoscopic cholecystectomy, and also given a leaflet with a diagram showing the site of injection.
An informed consent will be taken for the study in addition to the standard consent form for the procedure.
The surgeon will be unaware of the nature of the solution that he will inject into the gall bladder fossa (saline and bupivicaine injection will be shown to him pre op to check their details).
A member of the team will draw an envelope to randomize the patients in either arm and will brief the nurse about the injection without the surgeon becoming aware of this Solution will be carefully injected with a 0.2 mm epidural needle connected to a syringe percutaneously in the subserosal area taking great care not to inject intravascularly.
The rest of the operation will be performed as normal.

Pain levels will be assessed at various periods after the operation and the results will be compared.
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Marcaine
Primary outcome measure(s)

Post operative pain scores

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/01/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration50
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/08/2005
Date of final enrolment01/01/2006

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Portsmouth Road
Camberley
GU16 7UJ
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

06/09/2016: No publications found, verifying study status with principal investigator.